AI model predicts pancreatic cancer risk 3 years before diagnosis
Researchers at the Mayo Clinic have developed an AI model capable of predicting pancreatic cancer risk years before clinical diagnosis. The model utilizes longitudinal health records and routine lab data to identify high-risk patients.
Why it matters
Early detection of pancreatic cancer is critical for survival, and this tool could significantly improve patient outcomes by enabling earlier intervention.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: CDC from Pexels Researchers at Mayo Clinic have designed an artificial intelligence model that could predict an individual's risk of developing pancreatic cancer years before diagnosis. The research was presented at the American College of Surgeons (ACS) Clinical Congress 2026 in Washington, Sept. 26–29.
Pancreatic cancer is relatively rare but highly deadly, with about 67,000 new diagnoses and 52,000 deaths in 2026, according to the American Cancer Society. It accounts for about 3% of all new cancers but 8% of all cancer deaths.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in